首页> 美国卫生研究院文献>Cancer Medicine >Outcome of 449 adult patients with rhabdomyosarcoma: an observational ambispective nationwide study
【2h】

Outcome of 449 adult patients with rhabdomyosarcoma: an observational ambispective nationwide study

机译:449例成人横纹肌肉瘤患者的结局:一项全国性观察性研究

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Five‐year overall survival (OS) of localized RMS exceeds 70% in children (<18) but is very poor in adult patients. We analyzed the outcome and prognostic factors (PF) of a national series of adult patients with RMS in a large study. The study population consisted of two different cohorts: a retrospective cohort (157 adult patients treated in 13 reference centers between 05/1981 and 02/2010) and the prospective cohort (292 patients with RMS diagnosed and treated between 01/2010 and 12/2014 in France) included in the NetSarc database. A descriptive analysis of patients’ characteristics and prognostic factors was conducted on both series which were compared. In the retrospective series, histological subtypes were embryonal (E‐RMS) for 21% of patients, alveolar (A‐RMS) for 35% of patients, and “adult‐type” P‐RMS (pleomorphic, spindle cell RMS, not otherwise specified) (P) for 44% patients. This distribution significantly differed in the prospective cohort: A‐RMS: 18%; E‐RMS: 17%; and P‐RMS 65%. With a median follow‐up of 8.5 years, 5‐year OS for localized RMS and advanced RMS (with nodes and/or metastases) was 43% and 5%, respectively, (P < 0.0001), and median style="fixed-case">OS was 51, 33, and 16 months for E‐ style="fixed-case">RMS, A‐ style="fixed-case">RMS, and P‐ style="fixed-case">RMS, respectively, in the retrospective cohort. The median style="fixed-case">OS was less than 40 months for the prospective nationwide cohort for the entire population. In a multivariate analysis of the retrospective study, independent prognostic factors for style="fixed-case">OS were A‐ style="fixed-case">RMS, R0 resection, and adjuvant radiotherapy ( style="fixed-case">RT). For localized style="fixed-case">RMS, age and use of pediatric chemotherapy ( style="fixed-case">CT) regimen are independent prognostic factors. Adult patients with style="fixed-case">RMS have a poorer overall survival than pediatric patients, and survival varies considerably across histological subtypes.
机译:儿童(<18岁)的局部RMS的五年总体生存率(OS)超过70%,但在成年患者中则很差。在一项大型研究中,我们分析了一系列全国性RMS成人患者的结局和预后因素(PF)。研究人群包括两个不同的队列:回顾性队列(在05/1981和02/2010之间在13个参考中心治疗的157名成年患者)和前瞻性队列(在01/2010和12/2014之间诊断和治疗的RMS患者292) (在法国))。对两个系列的患者特征和预后因素进行描述性分析,并进行比较。在回顾性系列中,组织学亚型为21%的患者为胚胎(E-RMS),为35%的患者为肺泡(A-RMS),而“成人型” P-RMS(多形,梭形细胞RMS,其他情况除外) (P)适用于44%的患者。该分布在预期队列中有显着差异:A-RMS:18%; E-RMS:17%;和P-RMS 65%。中位随访时间为8.5年,局部RMS和晚期RMS(有淋巴结和/或转移灶)的5年OS分别为43%和5%(P <0.0001),中位数 style =“对于E- style =“ fixed-case”> RMS ,A- style =“ fixed-case”> RMS,fixed-case“> OS 为51、33和16个月回顾性队列中分别为和P- style =“ fixed-case”> RMS 。全国预期人群的中位数 style =“ fixed-case”> OS 少于40个月。在一项回顾性研究的多变量分析中, style =“ fixed-case”> OS 的独立预后因素为A‐ style =“ fixed-case”> RMS ,R0切除,和辅助放疗( style =“ fixed-case”> RT )。对于局部 style =“ fixed-case”> RMS ,年龄和小儿化疗方案( style =“ fixed-case”> CT )的使用是独立的预后因素。成年 style =“ fixed-case”> RMS 的患者的总生存期比儿科患者差,而且不同组织学亚型的生存期差异很大。

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号